InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,271.49
(
0.04%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DonShimoda

Send PM Follow Ignore
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

DonShimoda

Re: biotech_researcher post# 2835

Tuesday, 10/26/2010 7:01:05 AM

Tuesday, October 26, 2010 7:01:05 AM

Post# of 80490
Sorry to disagree but, imo, the financing decision says almost very little about "Harvey's confidence in Ridaforolimus in the SUCCEED trial." Ariad can't stop developing 534 AND 113 waiting for the Rida results. Rida is in Mercks hands and, given the delay, the company was faced with the choice to partner 534 now or raise $'s. Time will tell but I think they made the right choice. I just feel kind of stupid for not seeing this earlier.



Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up